Who is sponsoring NCT05454189?

NCT05454189 is sponsored by Essentia Health.

What drugs are being tested in NCT05454189?

Interventions in NCT05454189: Reduced IPD Flush Schedule, Standard IPD Flush Schedule.

What condition does NCT05454189 study?

NCT05454189 studies Maintenance of Implanted Port Devices.

Is NCT05454189 still recruiting?

NCT05454189 is currently recruiting now. Last updated 2 July 2025.

Last reviewed 2025-07-02 · How we verify

NCT05454189

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

Recruiting now NA Last updated 2 July 2025

What this trial tests

NA trial testing Reduced IPD Flush Schedule in Maintenance of Implanted Port Devices in 400 participants. Currently enrolling.

Timeline

11 October 2022

Primary endpoint
1 July 2025

31 December 2025

Quick facts

Lead sponsor	Essentia Health
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	400
Start date	11 October 2022
Primary completion	1 July 2025
Estimated completion	31 December 2025
Sites	17 locations across United States

Drugs / interventions tested

Reduced IPD Flush Schedule
Standard IPD Flush Schedule

Conditions studied

Maintenance of Implanted Port Devices — all drugs for Maintenance of Implanted Port Devices →

Sponsor

Essentia Health — full company profile →

Who can join

18 and older, any sex, with Maintenance of Implanted Port Devices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Essentia Health trials

Trials by the same sponsor.

NCT05173818 — Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms · Phase 2 · completed
NCT03187184 — Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic · NA · completed
NCT02626520 — Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla · Phase 2 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05454189 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Essentia Health
Last refreshed: 2 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05454189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing